Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

BACKGROUND: In this study, we evaluated the efficacy and toxicity of stereotactic body radiotherapy (SBRT) as replacement strategy of conventionally fractionated radiation therapy in stage III non-small cell lung cancer (NSCLC) patients unfit for concurrent chemoradiation therapy (CRT). METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Zhen, Fang, Fang, Cao, Yangsen, Zhu, Xiaofei, Yang, XiaoYu, Guo, Xueling, Zhang, Huojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463766/
https://www.ncbi.nlm.nih.gov/pubmed/37620952
http://dx.doi.org/10.1186/s13014-023-02333-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463766/
https://www.ncbi.nlm.nih.gov/pubmed/37620952
http://dx.doi.org/10.1186/s13014-023-02333-1

Ejemplares similares